quinelorane has been researched along with amphetamine in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 3 (75.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ashmeade, TE; Reavill, C; Routledge, C; Storey, VJ; Thorn, L | 1 |
| Austin, JD; Kim, JH; Perugini, M; Vezina, P | 1 |
| Marona-Lewicka, D; Nichols, DE; Thisted, RA | 1 |
| Barik, S; de Beaurepaire, R | 1 |
4 other study(ies) available for quinelorane and amphetamine
| Article | Year |
|---|---|
Evidence to suggest that agonist modulation of hyperlocomotion is via post-synaptic dopamine D2 or D3 receptors.
Topics: Amphetamine; Animals; Dopamine; Dopamine Agonists; Male; Microdialysis; Motor Activity; Nucleus Accumbens; Quinolines; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D2; Receptors, Dopamine D3 | 1997 |
Previous exposure to amphetamine enhances the subsequent locomotor response to a D1 dopamine receptor agonist when glutamate reuptake is inhibited.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Amphetamine; Animals; Benzazepines; Central Nervous System Stimulants; Dicarboxylic Acids; Dopamine Agonists; Drug Administration Schedule; Drug Synergism; Excitatory Amino Acid Agents; Glutamic Acid; Male; Microinjections; Motor Activity; Neurotransmitter Uptake Inhibitors; Nucleus Accumbens; Pyrrolidines; Quinolines; Rats; Receptors, Dopamine D1; Receptors, Dopamine D2; Time | 2001 |
Distinct temporal phases in the behavioral pharmacology of LSD: dopamine D2 receptor-mediated effects in the rat and implications for psychosis.
Topics: Amphetamine; Amphetamines; Animals; Apomorphine; Behavior, Animal; Cues; Discrimination Learning; Dopamine Agonists; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Dopamine Uptake Inhibitors; Dose-Response Relationship, Drug; Fluorobenzenes; Hallucinogens; Haloperidol; Indans; Injections, Intraperitoneal; Lysergic Acid Diethylamide; Male; Piperidines; Psychotic Disorders; Quinolines; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D2; Serotonin Antagonists; Serotonin Receptor Agonists; Time Factors | 2005 |
Dopamine D3 modulation of locomotor activity and sleep in the nucleus accumbens and in lobules 9 and 10 of the cerebellum in the rat.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Amisulpride; Amphetamine; Animals; Cerebellum; Dopamine Agonists; Dopamine Antagonists; Dopamine Uptake Inhibitors; Female; Haloperidol; Microinjections; Motor Activity; Naphthalenes; Nucleus Accumbens; Pyrrolidines; Quinolines; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D2; Receptors, Dopamine D3; Sleep; Sulpiride; Tetrahydronaphthalenes | 2005 |